Follicular Lymphoma Treatment Market

Follicular Lymphoma Treatment Market contains market size and forecasts of Follicular Lymphoma Treatment in Global, including the following market information:
Global Follicular Lymphoma Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Follicular Lymphoma Treatment market was valued at 1730.4 million in 2021 and is projected to reach US$ 2640 million by 2028, at a CAGR of 6.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Follicular Lymphoma Treatment include Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Celgene Corporation, Celldex Therapeutics, Inc., Celltrion, Inc., Cellular Biomedicine Group, Inc., Coherus BioSciences, Inc., CTI BioPharma Corp. and Curis, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Follicular Lymphoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Follicular Lymphoma Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Follicular Lymphoma Treatment Market Segment Percentages, by Type, 2021 (%)
Chemotherapy
Radiotherapy
Monoclonal Antibodies
Stem Cell Transplantation
Global Follicular Lymphoma Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Follicular Lymphoma Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Follicular Lymphoma Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Follicular Lymphoma Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Follicular Lymphoma Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Follicular Lymphoma Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Celgene Corporation
Celldex Therapeutics, Inc.
Celltrion, Inc.
Cellular Biomedicine Group, Inc.
Coherus BioSciences, Inc.
CTI BioPharma Corp.
Curis, Inc.
Dynavax Technologies Corporation
Eisai
EpiZyme, Inc.
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
Immune Design Corp.
ImmunoGen, Inc.